Session 18

Immunisation as a strategic investment

Leveraging the EU Stability and Growth Pact

Organised by Sanofi

Immunisation programmes represent one of the most cost-effective public health interventions available to governments. However, their economic value extends beyond traditional health and economic metrics. Evidence shows that immunisation might generate fiscal returns through healthier, more productive populations, increased tax revenues, and reduced spending on disability, social transfers, and avoidable healthcare costs. As Member States navigate fiscal consolidation and competing budget priorities, the EU Stability and Growth Pact provides a policy framework to align immunisation investments with fiscal sustainability objectives. This session explores how Fiscal Health Modelling can quantify these fiscal returns and support decision-making among finance ministries, treasury departments, and health policymakers. The session will present available evidence, discuss methodological approaches, and explore how immunisation can be positioned as a strategic fiscal investment within the context of the European Health Union, particularly given current challenges including vaccine hesitancy and the re-emergence of vaccine-preventable diseases.